
Kazia Therapeutics Limited KZIA
€ 6.25
-0.69%
Geschäftsbericht 2022
hinzugefügt 17.10.2022
Kazia Therapeutics Limited P/S 2011-2026 | KZIA
P/S Jährlich Kazia Therapeutics Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 21.9 | 2.41 | 3.15 |
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 21.9 | 2.41 | 9.14 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Veracyte
VCYT
|
5.89 | $ 31.01 | -5.46 % | $ 2.44 B | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Vir Biotechnology
VIR
|
14.9 | $ 8.47 | -5.47 % | $ 1.17 B | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Viking Therapeutics
VKTX
|
49.5 K | $ 32.67 | -4.61 % | $ 3.68 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
2.27 | - | - | $ 546 M | ||
|
Viridian Therapeutics
VRDN
|
42.2 | $ 27.39 | -2.87 % | $ 2.79 B | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Vertex Pharmaceuticals Incorporated
VRTX
|
10.4 | $ 437.99 | -3.47 % | $ 112 B | ||
|
Avid Bioservices
CDMO
|
3.03 | - | - | $ 789 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Verastem
VSTM
|
13.1 | $ 5.01 | -5.29 % | $ 347 M | ||
|
VistaGen Therapeutics
VTGN
|
151 | $ 0.56 | -7.23 % | $ 17.3 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
8.96 | $ 12.88 | -7.74 % | $ 1.95 B | ||
|
vTv Therapeutics
VTVT
|
24.4 | $ 38.69 | 2.35 % | $ 152 M | ||
|
Voyager Therapeutics
VYGR
|
5.97 | $ 3.97 | -4.0 % | $ 233 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
11 | $ 320.49 | -2.34 % | $ 42 B | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Cara Therapeutics
CARA
|
2.58 | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
0.0564 | - | - | $ 3.74 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Equillium
EQ
|
1.77 | $ 1.93 | -6.31 % | $ 111 M | ||
|
Amgen
AMGN
|
5.4 | $ 351.01 | -0.61 % | $ 189 B |